Scientists suggested that DNA methylation pathway is deregulated after enzalutamide resistance onset and that targeting DNA methyltransferases restored the sensitivity to enzalutamide in prostate cancer cells.
[Molecular Cancer therapeutics]
7992332
{7992332:AAAAAAAA}
apa
50
1
168627
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
